MEDZ Stock Overview
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Medartis Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF78.30 |
| 52 Week High | CHF99.30 |
| 52 Week Low | CHF63.50 |
| Beta | 0.99 |
| 1 Month Change | -4.40% |
| 3 Month Change | 0.51% |
| 1 Year Change | 10.44% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -35.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEDZ | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -1.4% | 1.7% | 1.3% |
| 1Y | 10.4% | -9.7% | 6.1% |
Return vs Industry: MEDZ exceeded the UK Medical Equipment industry which returned -10.1% over the past year.
Return vs Market: MEDZ exceeded the UK Market which returned 5.5% over the past year.
Price Volatility
| MEDZ volatility | |
|---|---|
| MEDZ Average Weekly Movement | 5.2% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: MEDZ has not had significant price volatility in the past 3 months.
Volatility Over Time: MEDZ's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 812 | Christoph Bronnimann | www.medartis.com |
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names.
Medartis Holding AG Fundamentals Summary
| MEDZ fundamental statistics | |
|---|---|
| Market cap | CHF1.06b |
| Earnings (TTM) | CHF619.00k |
| Revenue (TTM) | CHF212.01m |
1,709x
P/E Ratio5.0x
P/S RatioIs MEDZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDZ income statement (TTM) | |
|---|---|
| Revenue | CHF212.01m |
| Cost of Revenue | CHF44.43m |
| Gross Profit | CHF167.57m |
| Other Expenses | CHF166.95m |
| Earnings | CHF619.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 20, 2024
| Earnings per share (EPS) | 0.046 |
| Gross Margin | 79.04% |
| Net Profit Margin | 0.29% |
| Debt/Equity Ratio | 0.2% |
How did MEDZ perform over the long term?
See historical performance and comparison